Amgen (AMGN) PT Lowered to $216 at RBC Capital
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $411.84 +0.39%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $216.00 (from $217.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Canaccord Reiterates Hold Rating on Amgen (AMGN)
- Roche obesity drug shows 15.5% weight loss in diabetes trial
- Amgen (AMGN) PT Raised to $410 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
